Our research is one of the most prospective ways to create such medicines based on the synergy already registered and studied drugs in admixture with one another: in this case, we can obtain new classes of medications that are effective for other destinations, using the multi-component system. The need to create such mixtures is due to rapid adaptation to individual chemical compounds from viruses, bacteria, and cancer cells and due to the presence of a «sliding effect» during aging (concerns antihypertensives). For comparison, it is rare to find drugs that contain more than five different active substances in modern pharmacy. Typically, two or more component formulations are antihypertensives, antivirals, antibiotics, anti-cancer agents, and, at times. Developed by our team, directions already given concrete results: produced veterinary dynamic antiviral drug with a broad action spectrum; successfully applied in practice battlefield hemostatic powder «Gemma,» and the newly developed kvasi-living dry implant can radically change the catheterization practice in surgery. Research continues dynamic anti-cancer drug, synergistic kvasi-living antibiotics, antiatherosclerotic drugs, antihypertensive drugs, and medicines for Alzheimer’s disease treatment and for multiple sclerosis and diabetes; also, work is underway for the diagnostics creation of cancer, atherosclerosis, and pain medications.
